Datavault AI posts acquisition-fueled revenue jump but $37M Q2 loss, cash <$1M

Datavault AI Inc. (NASDAQ: WISA) - Q2 2025 (Form 10‑Q) - What's happening inside

Quick snapshot (amounts per filings - in thousands)

* Cash and cash equivalents: $662 (as of June 30, 2025)

* Total assets: $120,690

* Total liabilities: $46,621

* Stockholders' equity: $74,069

* Revenue - Q2 2025: $1,735 (Q2 2024: $345) - +403% (company attributes to CSI acquisition)

* Gross profit - Q2 2025: $35 (gross margin ~2%)

* Operating expenses - Q2 2025: $12,494 (R&D $4,224; S&M $1,742; G&A $6,528)

* Loss from operations - Q2 2025: $(12,459)

* Interest expense, net - Q2 2025: $(17,202)

* Change in fair value of 2025 notes (measured at fair value) - Q2 2025: $(8,804)

* Net loss - Q2 2025: $(37,116); Six months: $(46,679)

* Net loss per common share - Q2 2025: $(0.54); weighted average shares: 68,174,418

* Intangible assets, net (incl. patents/trademarks/customer relationships): $96,780; Goodwill: $19,135

* 2025 Convertible Notes (carrying/principal): 2025 Notes $20,957; CSI Convertible Notes $10,054

What's driving the numbers - inside the company

* Active acquisition strategy: completed CSI asset purchase (May 20, 2025) and earlier large asset purchases (EOS/Data Vault), which added significant intangibles ($96,780) and goodwill ($19,135). The CSI acquisition produced most of the Q2 revenue lift (Live Events revenue $1,432 for Q2).

* Financing and liability mix: multiple convertible note financings in 2025 (2025 Notes, DV Note, CSI Convertible Notes) and large warrant issuances. Company elected fair‑value accounting for several convertible notes -> material fair value volatility recorded in interest/other expense.

* Rapid expense build: R&D and G&A ramp tied to acquisitions, NYIAX work and product development; amortization of acquired intangibles (heavy non‑cash amortization) increased G&A.

* Partnerships and IP deals: exchange with NYIAX (share/exchange, IP cross‑license), software deals, and recent program/cloud commitments (IBM) and other purchase/assignment agreements signed as subsequent events.

Positive aspects (income statement & operational)

* Revenue growth: Q2 revenue up materially YoY (from $345 to $1,735) - acquisition synergies immediately contributing.

* Gross profit turned positive in the period (Q2 gross profit $35 vs $11 prior year); six‑month gross profit $104 vs a deficit prior year.

* Strategic assets added: meaningful intangible asset base (patents, customer relationships, internal tech) that supports future monetization and product expansion.

* Financing capacity: the company has been able to raise capital (Feb, Apr, May 2025 offerings; July/August 2025 follow‑ons) to fund acquisitions and operations.

Negative aspects / risks (income statement & liquidity)

* Large recurring losses and negative cash flow: Net loss Q2 $(37.1M); operating cash used $12.8M (six months) and cash at period end only $662k.

* Heavy non‑operational charges: $17.2M interest expense and $8.8M fair‑value charges tied to convertible notes drive large headline losses - volatile, model‑sensitive items.

* Going concern and short cash runway: the company discloses substantial doubt about ability to continue as a going concern and expects to need more financing within 12 months.

* Dilution and complex capital structure: many convertible instruments and warrants (31M+ warrants outstanding ranges), equity issuances tied to acquisitions - potential future dilution to common holders.

* Customer concentration and supply dependence: the filing notes concentration (two customers = 25% and 13% of AR) and reliance on single suppliers for key components.

* Nasdaq listing pressure / bid price risk: Nasdaq notified non‑compliance with minimum bid price (May 6, 2025); company has compliance period to cure - watch for delisting risk if price stays low.

* Large post‑period commitments: subsequent agreements include material cash/program commitments (e.g., IBM program payments noted in filings - large amounts that increase near‑term cash needs) and multiple asset purchase / royalty agreements (TGM royalty up to 15% until $15M paid).

Key operational takeaways - concise

* Growth strategy is acquisition‑led: CSI and prior asset purchases immediately lift revenue but add intangible amortization and integration costs.

* Capital structure is debt‑ and warrant‑heavy; management uses convertible financings that reduce immediate cash needs but increase accounting volatility and dilution.

* Liquidity is tight: <$1M cash at quarter end, substantial operating cash burn, and the company warns it must raise capital within 12 months - this is the primary near‑term risk.

* If you follow the stock: monitor upcoming financings, convertible note conversions, warrant exercises, revenue traction from CSI/live events, and any Nasdaq compliance developments.

Bottom line: Datavault AI Inc. (NASDAQ: WISA) shows early revenue acceleration from acquisitions but is operating with very limited cash, large non‑cash and financing‑related charges, and a complex capital structure. The business case depends on successful integration/monetization of acquired assets and the company's ability to secure near‑term financing without destroying investor value through heavy dilution.